Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia

被引：4
|
作者：
Jamy, Omer [1 ]
Lin, Karen [2 ]
Worth, Sarah [1 ]
Bachiashvili, Kimo [1 ]
Rangaraju, Sravanti [1 ]
Vachhani, Pankit [1 ]
Bhatia, Ravi [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA
[2] Grandview Med Ctr, Dept Med, Birmingham, AL USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 198卷 / 03期
关键词：
VENETOCLAX;
D O I：
10.1111/bjh.18229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E35 / E37
页数：3
相关论文
共 50 条
  • [21] Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    CANCERS, 2022, 14 (01)
  • [22] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [23] Ten-Day Decitabine with Venetoclax vs Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score-Matched Analysis
    Maiti, Abhishek
    DiNardo, Courtney
    Qiao, Wei
    Kadia, Tapan
    Jabbour, Elias
    Rausch, Caitlin
    Daver, Naval
    Short, Nicholas
    Borthakur, Gautam
    Pemmaraju, Naveen
    Yilmaz, Musa
    Alvarado, Yesid
    Montalbano, Kathryn
    Wade, Allison
    Maduike, Rita
    Guerrero, Julio
    Vaughan, Kenneth
    Bivins, Carol
    Pierce, Sherry
    Ning, Jing
    Ravandi, Farhad
    Kantarjian, Hagop
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S303 - S303
  • [24] Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant
    Ionescu, Filip
    David, Jerel C.
    Ravichandran, Apoorva
    Sallman, David A.
    Sweet, Kendra
    Komrokji, Rami S.
    Chan, Onyee
    Kuykendall, Andrew
    Padron, Eric
    Faramand, Rawan
    Bejanyan, Nelli
    Khimani, Farhad
    Elmariah, Hany
    Pidala, Joseph
    Mishra, Asmita
    Perez, Lia
    Nishihori, Taiga
    Lancet, Jeffrey E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (06) : 400 - 406
  • [25] Venetoclax plus hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia Two case reports
    Wang, Hongxia
    Bai, Junjun
    Pei, Zhixin
    Zhang, Bei
    Wang, Junjie
    Lian, Xingli
    Song, Qinglin
    MEDICINE, 2020, 99 (47) : E23265
  • [26] Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
    Saliba, Antoine N.
    John, August J.
    Kaufmann, Scott H.
    CANCER DRUG RESISTANCE, 2021, 4 (01) : 125 - 142
  • [27] Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
    Liu, Qingyang
    Zhang, Xiawei
    Lv, Lei
    Xu, Linming
    Jing, Yu
    Gao, Wenjing
    Wang, Lili
    Dou, Liping
    CANCER MEDICINE, 2025, 14 (05):
  • [28] Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid Leukemia
    Wille, Kai
    Dumke, Marvin
    Wilsdorf, Nadine
    Sadjadian, Parvis
    Schneider, Artur
    Jender-Bartling, Stephanie
    Kolatzki, Vera
    Horstmann, Anette
    Meixner, Raphael
    Jimenez-Munoz, Marina
    Fuchs, Christiane
    Tischler, Hans-Joachim
    Griesshammer, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 17 - 25
  • [29] Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents—a multicenter historical prospective study
    Ron Ram
    Odelia Amit
    Tsila Zuckerman
    Ronit Gurion
    Pia Raanani
    Yael Bar-On
    Irit Avivi
    Ofir Wolach
    Annals of Hematology, 2019, 98 : 1927 - 1932
  • [30] Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax plus hypomethylating agents
    Johnson, Isla M.
    Karrar, Omer
    Rana, Masooma
    Iftikhar, Moazah
    Chen, Sunny
    McCullough, Kristen
    Saliba, Antoine N.
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Litzow, Mark
    Hogan, William J.
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Hermann, Joerg
    Tefferi, Ayalew
    Gangat, Naseema
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1232 - 1237
12345